Showing results (101-110 of 5,395) with videos related to

Sort By:
Pageof 540
Frontiers in Neuroscience|October 24, 2017
Mitochondrial Bioenergetics Is Altered in Fibroblasts from Patients with Sporadic Alzheimer's DiseaseMaría J Pérez, Daniela P Ponce, Cesar Osorio-Fuentealba, et al.
Development (Cambridge, England)|October 25, 2013
Hox11 genes are required for regional patterning and integration of muscle, tendon and boneIlea T Swinehart, Aleesa J Schlientz, Christopher A Quintanilla, et al.
Free Radical Biology & Medicine|July 9, 2026
Cyclophilin D (CypD) promotes mitochondrial impairment, synaptic defects, cognitive loss, and tau pathology during agingMargrethe A Olesen, Eduardo Isla, Gail V W Johnson, et al.
Nature Communications|February 18, 2022
Dihydroceramide- and ceramide-profiling provides insights into human cardiometabolic disease etiologyC Wittenbecher, R Cuadrat, L Johnston, et al.
Frontiers in Behavioral Neuroscience|February 11, 2020
Effect of Alcohol on Hippocampal-Dependent Plasticity and Behavior: Role of Glutamatergic Synaptic TransmissionRodrigo G Mira, Matias Lira, Cheril Tapia-Rojas, et al.
Neurobiology of Disease|August 20, 2014
Phosphorylated tau potentiates Aβ-induced mitochondrial damage in mature neuronsRodrigo A Quintanilla, Rommy von Bernhardi, Juan A Godoy, et al.
Metabolism: Clinical and Experimental|June 1, 1991
The hepatocellular thyroid status of uremic rats estimated from the abundances of thyroid hormone-dependent nucleoplasmic proteinsB E Muñoz, C P Barsano, A Quintanilla, et al.
Free Radical Biology & Medicine|March 1, 2025
Cyclophilin D (CypD) ablation prevents neurodegeneration and cognitive damage induced by caspase-3 cleaved tauMargrethe A Olesen, Francisca Villavicencio-Tejo, Gail V W Johnson, et al.
Current Medicinal Chemistry|March 30, 2010
Enzyme replacement therapy in Fabry disease: influence on cardiac manifestationsL Caballero, V Climent, D Hernández-Romero, et al.
Pageof 540